WORLD HEALTH ORGANIZATION
Scientists discover differences in the blood samples of severe, mild COVID-19 patients
In the current study, published in the journal Cell Systems, the researchers assessed the blood component called plasma in COVID-19 patients for 'biomarkers' which could provide a reliable way to predict disease progression and severity.
PM applauds nurses for role in fight against coronavirus
"Today, we also reiterate our commitment to keep working for welfare of nurses and d...
Delhi HC asks authorities to treat as representation plea on WHO guidelines for disinfectants
The Delhi High Court asked the Centre and the D...
China delayed releasing coronavirus info, frustrating WHO
Throughout January, the World Health Organization publicly praised China for what it called a speedy response to the new coronavirus and thanked the Chinese government for sharing the genetic of the virus "immediately."
WHO trial is on fast track in India: Sheela Godbole, Senior Scientist, National Aids Research Institute
India plans to run the trial on 1,500 patients across 20-30 sites, Sheela Godbole, chief scientist at National AIDS Research Institute and national coordinator for the Solidarity trial in India, told ET’s Divya Rajagopal in an interview.
In days of discord, President Trump fans the flames
Over the last week, America reeled from 100,000 pandemic deaths, 40 million people out of work and cities in flames over a brutal police killing of a subdued black man. But Trump was on the attack against China, the World Health Organization, Big Tech, former President Barack Obama, a cable television host and the mayor of a riot-torn city.
View: COVID-19 changed the way we fly for good
The pandemic has helped us reset and plan the new normal, and ensure that aviation continues to be the safest and fastest mode of travel.
WHO denies its representative falsified Equatorial Guinea COVID-19 data
The Equatorial Guinea government asked WHO on May 26 to immediately replace the representative, Triphonie Nkurunziza, and the prime minister later told lawmakers that she had inflated the number of COVID-19 cases.
Scientists question validity of major hydroxychloroquine study
In an open letter to The Lancet’s editor, Richard Horton, and the paper’s authors, the scientists asked the journal to provide details about the provenance of the data and called for the study to be independently validated by the World Health Organization or another institution.
Wall Street ends mostly higher as US-China spat simmers
The Dow ended the session slightly lower, but all three indexes rose for the week and registered a second straight month of gains.
Two anti-inflammatory drugs found that may inhibit COVID-19 virus reproduction
Two anti-inflammatory drugs, one prescribed for humans and another for animals, may inhibit a key enzyme in the replication or reproduction of the novel coronavirus that causes COVID-19, according to a study.
China rejects report that it delayed COVID-19 information sharing with WHO
Foreign ministry spokesman Zhao Lijian made the remarks during a daily briefing in response to a question about the report by the Associated Press, which said the WHO was frustrated by significant delays in information sharing by Beijing as the coronavirus outbreak took hold in China in January.
Symptomless COVID-19 infection may be more prevalent than thought: Study
According to the findings, published in the journal Thorax, more than four out of five of passengers and crew who tested positive for the infection had no symptoms. The researchers also noted that there is a pressing need for accurate global data on how many people have been infected so far.
Physical distancing, masks, eye protection may help prevent COVID-19: Lancet study
The systematic review of existing evidence was commissioned by the World Health Organization, the researchers said.
US exit may hit WHO’s India work
The US is the largest donor to the WHO with a contribution of $400 million in 2018-19. WHO India’s country budget was reported to be a little above $100 million. An official aware of the development of WHO India office said there would be a short-term impact on the finances of the country office.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service